Please login or sign up to post and edit reviews.
Insights on GLP-1 Drugs and Medicare Advantage Trends with Jakob Emerson, Becker’s Healthcare
Publisher |
Becker's Healthcare
Media Type |
audio
Publication Date |
Sep 19, 2024
Episode Duration |
00:14:28

In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, joins Scott Becker to discuss the challenges surrounding GLP-1 drugs in the insurance space and the varied responses to Medicare Advantage headwinds. They explore Elevance Health’s strategies and share insights into how large and small insurers are navigating these issues.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review